Cargando…
A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
OBJECTIVE: Evidence suggests that chronic subclinical inflammation plays an important role in the pathogenesis of type 2 diabetes (T2DM). Circulating levels of interleukin (IL)-18 appear to be associated with a number of micro- and macrovascular comorbidities of obesity and T2DM. This study was desi...
Autores principales: | McKie, Elizabeth A., Reid, Juliet L., Mistry, Prafull C., DeWall, Stephen L., Abberley, Lee, Ambery, Philip D., Gil-Extremera, Blas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773233/ https://www.ncbi.nlm.nih.gov/pubmed/26930607 http://dx.doi.org/10.1371/journal.pone.0150018 |
Ejemplares similares
-
A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function
por: Wlodek, E., et al.
Publicado: (2021) -
Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study
por: Liao, Karen, et al.
Publicado: (2021) -
Lipid Disorders in Elderly Hypertensive Patients
por: Gil-Extremera, Blas
Publicado: (2012) -
Potential involvement of lactate and interleukin-6 in the appetite-regulatory hormonal response to an acute exercise bout
por: Islam, Hashim, et al.
Publicado: (2017) -
Monoclonal antibodies reactive with the mouse interleukin 5 receptor
Publicado: (1989)